China Money Network
Login
Join

Chinese Human Vaccine-Focused Biotech Firm Gets $36M In Series A Round

  • July 5, 2019 — 20:16 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese biotechnology firm Zhongyianke Biotech announced on Thursday that it has raised RMB250 million (US$36.35 million) in a series A round of financing from a... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: